Pfizer must pay $72.6 million in damages to three women who contended they developed breast cancer after taking the company's menopause drugs, a Philadelphia jury decided.
Pfizer to pay $72 million as jury finds drug caused cancer
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.